109 related articles for article (PubMed ID: 2109590)
21. An immunoglobulin fusion protein based on the gp120-CD4 receptor complex potently inhibits human immunodeficiency virus type 1 in vitro.
Vu JR; Fouts T; Bobb K; Burns J; McDermott B; Israel DI; Godfrey K; DeVico A
AIDS Res Hum Retroviruses; 2006 Jun; 22(6):477-90. PubMed ID: 16796521
[TBL] [Abstract][Full Text] [Related]
22. Influence of heavy chain constant regions on antigen binding and HIV-1 neutralization by a human monoclonal antibody.
Cavacini LA; Emes CL; Power J; Desharnais FD; Duval M; Montefiori D; Posner MR
J Immunol; 1995 Oct; 155(7):3638-44. PubMed ID: 7561063
[TBL] [Abstract][Full Text] [Related]
23. Heterodimer HLA-DM Fused with Constant Fragment of the Heavy Chain of the Human Immunoglobulin Accelerates Influenza Hemagglutinin HA306-318 Loading to HLA-DR1.
Mamedov AE; Ponomarenko NA; Belogurov AA; Gabibov AG
Bull Exp Biol Med; 2016 May; 161(1):92-5. PubMed ID: 27265131
[TBL] [Abstract][Full Text] [Related]
24. The Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1.
Liu L; Wang W; Matz J; Ye C; Bracq L; Delon J; Kimata JT; Chen Z; Benichou S; Zhou P
J Virol; 2016 Dec; 90(23):10642-10659. PubMed ID: 27654286
[TBL] [Abstract][Full Text] [Related]
25. Horse cytokine/IgG fusion proteins--mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines.
Wagner B; Robeson J; McCracken M; Wattrang E; Antczak DF
Vet Immunol Immunopathol; 2005 May; 105(1-2):1-14. PubMed ID: 15797470
[TBL] [Abstract][Full Text] [Related]
26. Recombinant extracellular domains of tetraspanin proteins are potent inhibitors of the infection of macrophages by human immunodeficiency virus type 1.
Ho SH; Martin F; Higginbottom A; Partridge LJ; Parthasarathy V; Moseley GW; Lopez P; Cheng-Mayer C; Monk PN
J Virol; 2006 Jul; 80(13):6487-96. PubMed ID: 16775336
[TBL] [Abstract][Full Text] [Related]
27. CD4-IgG binding threshold for inactivation of human immunodeficiency virus type 1.
Berkower I; Mostowski H; Bull TE; Murphy D
J Infect Dis; 1996 Apr; 173(4):863-9. PubMed ID: 8603964
[TBL] [Abstract][Full Text] [Related]
28. Improving the efficacy of antibody-interleukin 2 fusion proteins by reducing their interaction with Fc receptors.
Gillies SD; Lan Y; Lo KM; Super M; Wesolowski J
Cancer Res; 1999 May; 59(9):2159-66. PubMed ID: 10232603
[TBL] [Abstract][Full Text] [Related]
29. Anti-HIV activity of CD4-Pseudomonas exotoxin on infected primary human lymphocytes and monocyte/macrophages.
Ashorn P; Englund G; Martin MA; Moss B; Berger EA
J Infect Dis; 1991 Apr; 163(4):703-9. PubMed ID: 2010626
[TBL] [Abstract][Full Text] [Related]
30. Fc receptors for IgG (Fc gamma Rs) on human monocytes and macrophages are not infectivity receptors for human immunodeficiency virus type 1 (HIV-1): studies using bispecific antibodies to target HIV-1 to various myeloid cell surface molecules, including the Fc gamma R.
Connor RI; Dinces NB; Howell AL; Romet-Lemonne JL; Pasquali JL; Fanger MW
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9593-7. PubMed ID: 1835086
[TBL] [Abstract][Full Text] [Related]
31. Conserved N-linked oligosaccharides of the C-terminal portion of human immunodeficiency virus type 1 gp120 and viral susceptibility to neutralizing antibodies.
Hemming A; Gram GJ; Bolmstedt A; Losman B; Hansen JE; Ricksten A; Olofsson S
Arch Virol; 1996; 141(11):2139-51. PubMed ID: 8973529
[TBL] [Abstract][Full Text] [Related]
32. Involvement of the complement system in antibody-mediated post-exposure protection against human immunodeficiency virus type 1.
Gauduin MC; Weir R; Fung MS; Koup RA
AIDS Res Hum Retroviruses; 1998 Feb; 14(3):205-11. PubMed ID: 9491910
[TBL] [Abstract][Full Text] [Related]
33. The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro.
Batova A; Kamps A; Gillies SD; Reisfeld RA; Yu AL
Clin Cancer Res; 1999 Dec; 5(12):4259-63. PubMed ID: 10632368
[TBL] [Abstract][Full Text] [Related]
34. Targeting cell-free HIV and virally-infected cells with anti-HLA-DR immunoliposomes containing amphotericin B.
Bestman-Smith J; Désormeaux A; Tremblay MJ; Bergeron MG
AIDS; 2000 Nov; 14(16):2457-65. PubMed ID: 11101055
[TBL] [Abstract][Full Text] [Related]
35. Analysis of Complement-Mediated Lysis of Simian Immunodeficiency Virus (SIV) and SIV-Infected Cells Reveals Sex Differences in Vaccine-Induced Immune Responses in Rhesus Macaques.
Miller-Novak LK; Das J; Musich TA; Demberg T; Weiner JA; Venzon DJ; Mohanram V; Vargas-Inchaustegui DA; Tuero I; Ackerman ME; Alter G; Robert-Guroff M
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021899
[TBL] [Abstract][Full Text] [Related]
36. Functional activity of an HIV-1 neutralizing IgG human monoclonal antibody: ADCC and complement-mediated lysis.
Posner MR; Elboim HS; Cannon T; Cavacini L; Hideshima T
AIDS Res Hum Retroviruses; 1992 May; 8(5):553-8. PubMed ID: 1381201
[TBL] [Abstract][Full Text] [Related]
37. Molecular insights into the inhibition of HIV-1 infection using a CD4 domain-1-specific monoclonal antibody.
Hou W; Fang C; Liu J; Yu H; Qi J; Zhang Z; Yuan R; Xiong D; Gao S; Adam Yuan Y; Li S; Gu Y; Xia N
Antiviral Res; 2015 Oct; 122():101-11. PubMed ID: 26259811
[TBL] [Abstract][Full Text] [Related]
38. Complement can neutralize HIV-1 plasma virus by a C5-independent mechanism.
Sullivan BL; Takefman DM; Spear GT
Virology; 1998 Sep; 248(2):173-81. PubMed ID: 9721226
[TBL] [Abstract][Full Text] [Related]
39. In vitro selective elimination of HIV-infected cells from peripheral blood in AIDS patients by the immunotoxin DAB389CD4.
Martín-Serrano J; Folgueira L; Laín de Lera T; Pedraza MA; Lemichez E; Sánchez-Palomino S; Noriega AR; Boquet P; Alcamí J
AIDS; 1998 May; 12(8):859-63. PubMed ID: 9631138
[TBL] [Abstract][Full Text] [Related]
40. Human interleukin-2-IgM heavy-chain-fusion proteins are cytotoxic for cells expressing the IL2 receptor.
Vie H; Gauthier T; Breathnach R; Bonneville M; Godard A; Dietrich J; Karam G; Gesnel MC; Peyrat MA; Jacques Y
Transplant Proc; 1993 Feb; 25(1 Pt 1):741-2. PubMed ID: 8438463
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
